The Mammalian Response to Virus Infection Is Independent of Small RNA Silencing

Cell Reports

Volumn 8, Issue 1, 2014, Pages 114-125

  Backes, Simone ^a   Langlois, Ryan A ^a   Schmid, Sonja ^a   Varble, Andrew ^a   Shim, Jaehee V ^a   Sachs, David ^a   tenOever, Benjamin R ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; MICRORNA; SMALL INTERFERING RNA; VIRUS RNA; RNA; SMALL RNA; UNCLASSIFIED DRUG; RNA INDUCED SILENCING COMPLEX;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; GENE FUNCTION; GENE LOSS; GENE SILENCING; IMMUNE RESPONSE; IN VIVO STUDY; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VESICULAR STOMATITIS; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TITRATION; BONE MARROW DERIVED MACROPHAGE; BORNA DISEASE VIRUS; EX VIVO STUDY; IN VITRO STUDY; ORTHOMYXOVIRUS; RHABDOVIRUS; RNA VIRUS INFECTION; TOGAVIRUS; TRANSCRIPTION REGULATION; VIRUS IMMUNITY; ANIMAL; CELL CULTURE; CHLOROCEBUS AETHIOPS; GENETICS; HAMSTER; METABOLISM; PHYSIOLOGY; RHABDOVIRUS INFECTION; VERO CELL LINE; VESICULOVIRUS;

ARTHROPODA; MAMMALIA; NEMATODA; RNA VIRUSES;

ANIMALS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; CRICETINAE; INTERFERONS; MICE; RHABDOVIRIDAE INFECTIONS; RNA INTERFERENCE; RNA, SMALL INTERFERING; RNA-INDUCED SILENCING COMPLEX; VERO CELLS; VESICULOVIRUS;

EID: 84904038337     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.05.038     Document Type: Article

References (84)

1. Ameres S.L., Horwich M.D., Hung J.H., Xu J., Ghildiyal M., Weng Z., Zamore P.D. Target RNA-directed trimming and tailing of small silencing RNAs. Science 2010, 328:1534-1539.
2. Aravin A.A., Hannon G.J. Small RNA silencing pathways in germ and stem cells. Cold Spring Harb. Symp. Quant. Biol. 2008, 73:283-290.
3. Backes S., Shapiro J.S., Sabin L.R., Pham A.M., Reyes I., Moss B., Cherry S., tenOever B.R. Degradation of host microRNAs by poxvirus poly(A) polymerase reveals terminal RNA methylation as a protective antiviral mechanism. Cell Host Microbe 2012, 12:200-210.
4. Barnes D., Kunitomi M., Vignuzzi M., Saksela K., Andino R. Harnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virus vaccines. Cell Host Microbe 2008, 4:239-248.
5. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
6. Bartel D.P., Chen C.Z. Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat. Rev. Genet. 2004, 5:396-400.
7. Bowie A.G., Unterholzner L. Viral evasion and subversion of pattern-recognition receptor signalling. Nat. Rev. Immunol. 2008, 8:911-922.
8. Bucher E., Hemmes H., de Haan P., Goldbach R., Prins M. The influenza A virus NS1 protein binds small interfering RNAs and suppresses RNA silencing in plants. J.Gen. Virol. 2004, 85:983-991.
9. Calabrese J.M., Seila A.C., Yeo G.W., Sharp P.A. RNA sequence analysis defines Dicer's role in mouse embryonic stem cells. Proc. Natl. Acad. Sci. USA 2007, 104:18097-18102.
10. Carthew R.W., Sontheimer E.J. Origins and mechanisms of miRNAs and siRNAs. Cell 2009, 136:642-655.
11. Cawood R., Chen H.H., Carroll F., Bazan-Peregrino M., van Rooijen N., Seymour L.W. Use of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cells. PLoS Pathog. 2009, 5:e1000440.
12. Chao J.A., Lee J.H., Chapados B.R., Debler E.W., Schneemann A., Williamson J.R. Dual modes of RNA-silencing suppression by Flock House virus protein B2. Nat. Struct. Mol. Biol. 2005, 12:952-957.
13. Chou Y.T., Tam B., Linay F., Lai E.C. Transgenic inhibitors of RNA interference in Drosophila. Fly (Austin) 2007, 1:311-316.
14. Chua M.A., Schmid S., Perez J.T., Langlois R.A., Tenoever B.R. Influenza A virus utilizes suboptimal splicing to coordinate the timing of infection. Cell Reports 2013, 3:23-29.
15. Cullen B.R., Cherry S., tenOever B.R. Is RNA interference a physiologically relevant innate antiviral immune response in mammals?. Cell Host Microbe 2013, 14:374-378.
16. Delgadillo M.O., Sáenz P., Salvador B., García J.A., Simón-Mateo C. Human influenza virus NS1 protein enhances viral pathogenicity and acts as an RNA silencing suppressor in plants. J.Gen. Virol. 2004, 85:993-999.
17. Ding S.W., Voinnet O. Antiviral immunity directed by small RNAs. Cell 2007, 130:413-426.
18. Donaszi-Ivanov A., Mohorianu I., Dalmay T., Powell P.P. Small RNA analysis in Sindbis virus infected human HEK293 cells. PLoS ONE 2013, 8:e84070.
19. Ebert M.S., Sharp P.A. Roles for microRNAs in conferring robustness to biological processes. Cell 2012, 149:515-524.
20. Edge R.E., Falls T.J., Brown C.W., Lichty B.D., Atkins H., Bell J.C. A let-7 MicroRNA-sensitive vesicular stomatitis virus demonstrates tumor-specific replication. Mol. Ther. 2008, 16:1437-1443.
21. Fabozzi G., Nabel C.S., Dolan M.A., Sullivan N.J. Ebolavirus proteins suppress the effects of small interfering RNA by direct interaction with the mammalian RNA interference pathway. J.Virol. 2011, 85:2512-2523.
22. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998, 391:806-811.
23. García-Sastre A., Egorov A., Matassov D., Brandt S., Levy D.E., Durbin J.E., Palese P., Muster T. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 1998, 252:324-330.
24. Girardi E., Chane-Woon-Ming B., Messmer M., Kaukinen P., Pfeffer S. Identification of RNase L-dependent, 3'-end-modified, viral small RNAs in Sindbis virus-infected mammalian cells. MBio 2013, 4. e00698-e13.
25. Gottwein E., Cullen B.R. Viral and cellular microRNAs as determinants of viral pathogenesis and immunity. Cell Host Microbe 2008, 3:375-387.
26. Guo Z., Shao L., Zheng L., Du Q., Li P., John B., Geller D.A. miRNA-939 regulates human inducible nitric oxide synthase posttranscriptional gene expression in human hepatocytes. Proc. Natl. Acad. Sci. USA 2012, 109:5826-5831.
27. Haasnoot J., de Vries W., Geutjes E.J., Prins M., de Haan P., Berkhout B. The Ebola virus VP35 protein is a suppressor of RNA silencing. PLoS Pathog. 2007, 3:e86.
28. Hutvágner G., Zamore P.D. RNAi: nature abhors a double-strand. Curr. Opin. Genet. Dev. 2002, 12:225-232.
29. Junt T., Moseman E.A., Iannacone M., Massberg S., Lang P.A., Boes M., Fink K., Henrickson S.E., Shayakhmetov D.M., Di Paolo N.C., et al. Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature 2007, 450:110-114.
30. Kelly E.J., Hadac E.M., Greiner S., Russell S.J. Engineering microRNA responsiveness to decrease virus pathogenicity. Nat. Med. 2008, 14:1278-1283.
31. Kelly E.J., Nace R., Barber G.N., Russell S.J. Attenuation of vesicular stomatitis virus encephalitis through microRNA targeting. J.Virol. 2010, 84:1550-1562.
32. Kemp C., Imler J.L. Antiviral immunity in Drosophila. Curr. Opin. Immunol. 2009, 21:3-9.
33. Langlois R.A., Shapiro J.S., Pham A.M., tenOever B.R. Invivo delivery of cytoplasmic RNA virus-derived miRNAs. Mol. Ther. 2012, 20:367-375.
34. Langlois R.A., Varble A., Chua M.A., García-Sastre A., tenOever B.R. Hematopoietic-specific targeting of influenza A virus reveals replication requirements for induction of antiviral immune responses. Proc. Natl. Acad. Sci. USA 2012, 109:12117-12122.
35. Langlois R.A., Albrecht R.A., Kimble B., Sutton T., Shapiro J.S., Finch C., Angel M., Chua M.A., Gonzalez-Reiche A.S., Xu K., et al. MicroRNA-based strategy to mitigate the risk of gain-of-function influenza studies. Nat. Biotechnol. 2013, 31:844-847.
36. Lauring A.S., Jones J.O., Andino R. Rationalizing the development of live attenuated virus vaccines. Nat. Biotechnol. 2010, 28:573-579.
37. Leung A.K., Vyas S., Rood J.E., Bhutkar A., Sharp P.A., Chang P. Poly(ADP-ribose) regulates stress responses and microRNA activity in the cytoplasm. Mol. Cell 2011, 42:489-499.
38. Li H., Li W.X., Ding S.W. Induction and suppression of RNA silencing by an animal virus. Science 2002, 296:1319-1321.
39. Li W.X., Li H., Lu R., Li F., Dus M., Atkinson P., Brydon E.W., Johnson K.L., García-Sastre A., Ball L.A., et al. Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing. Proc. Natl. Acad. Sci. USA 2004, 101:1350-1355.
40. Li Y., Lu J., Han Y., Fan X., Ding S.W. RNA interference functions as an antiviral immunity mechanism in mammals. Science 2013, 342:231-234.
41. Liu X., Ru J., Zhang J., Zhu L.H., Liu M., Li X., Tang H. miR-23a targets interferon regulatory factor 1 and modulates cellular proliferation and paclitaxel-induced apoptosis in gastric adenocarcinoma cells. PLoS ONE 2013, 8:e64707.
42. Liu Z., Wang D., Hu Y., Zhou G., Zhu C., Yu Q., Chi Y., Cao Y., Jia C., Zou Q. MicroRNA-146a negatively regulates PTGS2 expression induced by Helicobacter pylori in human gastric epithelial cells. J.Gastroenterol. 2013, 48:86-92.
43. Maillard P.V., Ciaudo C., Marchais A., Li Y., Jay F., Ding S.W., Voinnet O. Antiviral RNA interference in mammalian cells. Science 2013, 342:235-238.
44. Marquez R.T., Wendlandt E., Galle C.S., Keck K., McCaffrey A.P. MicroRNA-21 is upregulated during the proliferative phase of liver regeneration, targets Pellino-1, and inhibits NF-kappaB signaling. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 298:G535-G541.
45. Mibayashi M., Martínez-Sobrido L., Loo Y.M., Cárdenas W.B., Gale M., García-Sastre A. Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J.Virol. 2007, 81:514-524.
46. Mordstein M., Neugebauer E., Ditt V., Jessen B., Rieger T., Falcone V., Sorgeloos F., Ehl S., Mayer D., Kochs G., et al. Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J.Virol. 2010, 84:5670-5677.
47. Mueller S., Gausson V., Vodovar N., Deddouche S., Troxler L., Perot J., Pfeffer S., Hoffmann J.A., Saleh M.C., Imler J.L. RNAi-mediated immunity provides strong protection against the negative-strand RNA vesicular stomatitis virus in Drosophila. Proc. Natl. Acad. Sci. USA 2010, 107:19390-19395.
48. Nayak A., Berry B., Tassetto M., Kunitomi M., Acevedo A., Deng C., Krutchinsky A., Gross J., Antoniewski C., Andino R. Cricket paralysis virus antagonizes Argonaute 2 to modulate antiviral defense in Drosophila. Nat. Struct. Mol. Biol. 2010, 17:547-554.
49. Nayak A., Tassetto M., Kunitomi M., Andino R. RNA interference-mediated intrinsic antiviral immunity in invertebrates. Curr. Top. Microbiol. Immunol. 2013, 371:183-200.
50. Otsuka M., Jing Q., Georgel P., New L., Chen J., Mols J., Kang Y.J., Jiang Z., Du X., Cook R., et al. Hypersusceptibility to vesicular stomatitis virus infection in Dicer1-deficient mice is due to impaired miR24 and miR93 expression. Immunity 2007, 27:123-134.
51. Pall G.S., Hamilton A.J. Improved northern blot method for enhanced detection of small RNA. Nat. Protoc. 2008, 3:1077-1084.
52. Parameswaran P., Sklan E., Wilkins C., Burgon T., Samuel M.A., Lu R., Ansel K.M., Heissmeyer V., Einav S., Jackson W., et al. Six RNA viruses and forty-one hosts: viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems. PLoS Pathog. 2010, 6:e1000764.
53. Perez J.T., Pham A.M., Lorini M.H., Chua M.A., Steel J., tenOever B.R. MicroRNA-mediated species-specific attenuation of influenza A virus. Nat. Biotechnol. 2009, 27:572-576.
54. Petrillo J.E., Venter P.A., Short J.R., Gopal R., Deddouche S., Lamiable O., Imler J.L., Schneemann A. Cytoplasmic granule formation and translational inhibition of nodaviral RNAs in the absence of the double-stranded RNA binding protein B2. J.Virol. 2013, 87:13409-13421.
55. Pfeffer S., Zavolan M., Grässer F.A., Chien M., Russo J.J., Ju J., John B., Enright A.J., Marks D., Sander C., Tuschl T. Identification of virus-encoded microRNAs. Science 2004, 304:734-736.
56. Pham A.M., Langlois R.A., TenOever B.R. Replication in cells of hematopoietic origin is necessary for Dengue virus dissemination. PLoS Pathog. 2012, 8:e1002465.
57. Pichlmair A., Schulz O., Tan C.P., Näslund T.I., Liljeström P., Weber F., Reis e Sousa C. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 2006, 314:997-1001.
58. Prins K.C., Delpeut S., Leung D.W., Reynard O., Volchkova V.A., Reid S.P., Ramanan P., Cárdenas W.B., Amarasinghe G.K., Volchkov V.E., Basler C.F. Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs. J.Virol. 2010, 84:3004-3015.
59. Qi N., Zhang L., Qiu Y., Wang Z., Si J., Liu Y., Xiang X., Xie J., Qin C.F., Zhou X., Hu Y. Targeting of dicer-2 and RNA by a viral RNA silencing suppressor in Drosophila cells. J.Virol. 2012, 86:5763-5773.
60. Ratcliff F.G., MacFarlane S.A., Baulcombe D.C. Gene silencing without DNA. rna-mediated cross-protection between viruses. Plant Cell 1999, 11:1207-1216.
61. Rauch I., Müller M., Decker T. The regulation of inflammation by interferons and their STATs. JAK-STAT 2013, 2:e23820.
62. Sabin L.R., Zheng Q., Thekkat P., Yang J., Hannon G.J., Gregory B.D., Tudor M., Cherry S. Dicer-2 processes diverse viral RNA species. PLoS ONE 2013, 8:e55458.
63. Saleh M.C., Tassetto M., van Rij R.P., Goic B., Gausson V., Berry B., Jacquier C., Antoniewski C., Andino R. Antiviral immunity in Drosophila requires systemic RNA interference spread. Nature 2009, 458:346-350.
64. Schmid S., Zony L.C., tenOever B.R. A versatile RNA vector for delivery of coding and noncoding RNAs. J.Virol. 2014, 88:2333-2336.
65. Schoggins J.W., Rice C.M. Interferon-stimulated genes and their antiviral effector functions. Curr. Opin. Virol. 2011, 1:519-525.
66. Schwach F., Vaistij F.E., Jones L., Baulcombe D.C. An RNA-dependent RNA polymerase prevents meristem invasion by potato virus X and is required for the activity but not the production of a systemic silencing signal. Plant Physiol. 2005, 138:1842-1852.
67. Seo G.J., Kincaid R.P., Phanaksri T., Burke J.M., Pare J.M., Cox J.E., Hsiang T.Y., Krug R.M., Sullivan C.S. Reciprocal inhibition between intracellular antiviral signaling and the RNAi machinery in mammalian cells. Cell Host Microbe 2013, 14:435-445.
68. Shan S.W., Lee D.Y., Deng Z., Shatseva T., Jeyapalan Z., Du W.W., Zhang Y., Xuan J.W., Yee S.P., Siragam V., Yang B.B. MicroRNA MiR-17 retards tissue growth and represses fibronectin expression. Nat. Cell Biol. 2009, 11:1031-1038.
69. Shapiro J.S., Varble A., Pham A.M., Tenoever B.R. Noncanonical cytoplasmic processing of viral microRNAs. RNA 2010, 16:2068-2074.
70. Shapiro J.S., Langlois R.A., Pham A.M., Tenoever B.R. Evidence for a cytoplasmic microprocessor of pri-miRNAs. RNA 2012, 18:1338-1346.
71. Shapiro J.S., Schmid S., Aguado L.C., Sabin L.R., Yasunaga A., Shim J.V., Sachs D., Cherry S., tenOever B.R. Drosha as an interferon-independent antiviral factor. Proc. Natl. Acad. Sci. USA 2014, 111:7108-7113.
72. Stojdl D.F., Lichty B.D., tenOever B.R., Paterson J.M., Power A.T., Knowles S., Marius R., Reynard J., Poliquin L., Atkins H., et al. VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 2003, 4:263-275.
73. Taganov K.D., Boldin M.P., Chang K.J., Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 2006, 103:12481-12486.
74. tenOever B.R. RNA viruses and the host microRNA machinery. Nat. Rev. Microbiol. 2013, 11:169-180.
75. Thomas M., Lange-Grünweller K., Weirauch U., Gutsch D., Aigner A., Grünweller A., Hartmann R.K. The proto-oncogene Pim-1 is a target of miR-33a. Oncogene 2012, 31:918-928.
76. Umbach J.L., Cullen B.R. The role of RNAi and microRNAs in animal virus replication and antiviral immunity. Genes Dev. 2009, 23:1151-1164.
77. van Rij R.P., Saleh M.C., Berry B., Foo C., Houk A., Antoniewski C., Andino R. The RNA silencing endonuclease Argonaute 2 mediates specific antiviral immunity in Drosophila melanogaster. Genes Dev. 2006, 20:2985-2995.
78. Varble A., Chua M.A., Perez J.T., Manicassamy B., García-Sastre A., tenOever B.R. Engineered RNA viral synthesis of microRNAs. Proc. Natl. Acad. Sci. USA 2010, 107:11519-11524.
79. Varble A., Benitez A.A., Schmid S., Sachs D., Shim J.V., Rodriguez-Barrueco R., Panis M., Crumiller M., Silva J.M., Sachidanandam R., tenOever B.R. An invivo RNAi screening approach to identify host determinants of virus replication. Cell Host Microbe 2013, 14:346-356.
80. Vogel S.N., Fertsch D. Macrophages from endotoxin-hyporesponsive (Lpsd) C3H/HeJ mice are permissive for vesicular stomatitis virus because of reduced levels of endogenous interferon: possible mechanism for natural resistance to virus infection. J.Virol. 1987, 61:812-818.
81. Weber F., Kochs G., Haller O., Staeheli P. Viral evasion of the interferon system: old viruses, new tricks. J.Interferon Cytokine Res. 2003, 23:209-213.
82. Wilkins C., Dishongh R., Moore S.C., Whitt M.A., Chow M., Machaca K. RNA interference is an antiviral defence mechanism in Caenorhabditis elegans. Nature 2005, 436:1044-1047.
83. Yu G.Y., He G., Li C.Y., Tang M., Grivennikov S., Tsai W.T., Wu M.S., Hsu C.W., Tsai Y., Wang L.H., Karin M. Hepatic expression of HCV RNA-dependent RNA polymerase triggers innate immune signaling and cytokine production. Mol. Cell 2012, 48:313-321.
84. Zamore P.D., Tuschl T., Sharp P.A., Bartel D.P. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 2000, 101:25-33.